Clinical trials
Phase 2/3 Arthritis, Rheumatoid trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 4 |
| Cui xuejun | 3 |
| Institute for Developing Science and Health Initiatives, Bangladesh | 1 |
| Paul R Fortin | 1 |
| Örebro University, Sweden | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 10 |
| Lupus Erythematosus, Systemic | 1 |
| Osteoarthritis | 1 |
| Scleroderma, Diffuse | 1 |
| Scleroderma, Systemic | 1 |
| Systemic Vasculitis | 1 |
| Undifferentiated Connective Tissue Diseases | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.